133 related articles for article (PubMed ID: 32707539)
1. Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
Fukui N; Yawata T; Nakajo T; Kawanishi Y; Higashi Y; Yamashita T; Aratake T; Honke K; Ueba T
J Neurosurg; 2020 Jul; 134(6):1772-1782. PubMed ID: 32707539
[TBL] [Abstract][Full Text] [Related]
2. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
3. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract][Full Text] [Related]
4. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma.
Chen CH; Chen PY; Lin YY; Feng LY; Chen SH; Chen CY; Huang YC; Huang CY; Jung SM; Chen LY; Wei KC
J Neurosurg; 2019 Jan; 132(1):168-179. PubMed ID: 30641835
[TBL] [Abstract][Full Text] [Related]
6. H
Zhou M; Jiang N; Fan J; Fu S; Luo H; Su P; Zhang M; Shi H; Zeng J; Huang Y; Li Y; Shen H; Zhang A; Li R
J Control Release; 2019 Sep; 310():24-35. PubMed ID: 31404556
[TBL] [Abstract][Full Text] [Related]
7. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of folic acid/polyamide-amine as a miR-7 vector on the growth of glioma in mice].
Liu XZ; Su ZG; Jiang ZM; Li G; Song J; Huang K; Wang L; Chen L; Liu ZL
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):325-30. PubMed ID: 22883450
[TBL] [Abstract][Full Text] [Related]
9.
Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
[TBL] [Abstract][Full Text] [Related]
10. Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo.
Li Y; Li L; Wu Z; Wang L; Wu Y; Li D; Ma U; Shao J; Yu H; Wang D
Oncol Rep; 2017 Jul; 38(1):325-335. PubMed ID: 28560406
[TBL] [Abstract][Full Text] [Related]
11. CD146 is highly expressed in glioma stem cells and acts as a cell cycle regulator.
Yawata T; Higashi Y; Kawanishi Y; Nakajo T; Fukui N; Fukuda H; Ueba T
J Neurooncol; 2019 Aug; 144(1):21-32. PubMed ID: 31147892
[TBL] [Abstract][Full Text] [Related]
12. A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment.
Gao S; Tian H; Xing Z; Zhang D; Guo Y; Guo Z; Zhu X; Chen X
J Control Release; 2016 Dec; 243():357-369. PubMed ID: 27794494
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
14. Magnetofection based on superparamagnetic iron oxide nanoparticle-mediated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cells.
Fang K; Liu P; Dong S; Guo Y; Cui X; Zhu X; Li X; Jiang L; Liu T; Wu Y
Int J Oncol; 2016 Aug; 49(2):509-18. PubMed ID: 27277755
[TBL] [Abstract][Full Text] [Related]
15. Suppressing the malignant phenotypes of glioma cells by lentiviral delivery of small hairpin RNA targeting hypoxia-inducible factor-1α.
Dong CG; Wu WK; Feng SY; Yu J; Shao JF; He GM
Int J Clin Exp Pathol; 2013; 6(11):2323-32. PubMed ID: 24228093
[TBL] [Abstract][Full Text] [Related]
16. SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells.
Huang SK; Qian JX; Yuan BQ; Lin YY; Ye ZX; Huang SS
Cell Mol Biol (Noisy-le-grand); 2014 Nov; 60(4):30-6. PubMed ID: 25481014
[TBL] [Abstract][Full Text] [Related]
17. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
18. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.
Gao S; Li J; Jiang C; Hong B; Hao B
Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669
[TBL] [Abstract][Full Text] [Related]
19. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma.
Wang S; Reinhard S; Li C; Qian M; Jiang H; Du Y; Lächelt U; Lu W; Wagner E; Huang R
Mol Ther; 2017 Jul; 25(7):1556-1566. PubMed ID: 28502470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
